Ultime notizie per Tenet Healthcare (NYSE:THC) Azioni

Tenet Healthcare

Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Tenet Healthcare Corporation Common Stock

Tenet Healthcare Corp

THC BIOMED INTL LTD ORD by THC BioMed Intl Ltd.

THC Biomed International Ltd

TH International Limited - Ordinary shares

TH International Ltd

Thunder Bridge Capital Partners IV, Inc. - Class A Common Stock

Thunder Bridge Capital Partners IV Inc

Thunder Bridge Capital Partners IV, Inc. - Unit

Thunder Bridge Capital Partners IV, Inc. - Warrant

THC THERAPEUTICS INC by THC Therapeutics, Inc.

THC Therapeutics Inc

Spinnaker ETF Series Cannabis ETF

Deep-pocketed investors have adopted a bearish approach towards Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in THC usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Tenet Healthcare. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 36% leaning bullish and 54% bearish. Among these notable options, 2 are puts, totaling $50,501, and 9 are calls, amounting to $2,559,675.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $80.0 to $170.0 for Tenet Healthcare over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Tenet Healthcare's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tenet Healthcare's whale activity within a strike price range from $80.0 to $170.0 in the last 30 days. 
<h3>Tenet Healthcare Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732216007_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$68.0</td>
<td>$68.0</td>
<td>$68.0</td>
<td>$80.00</td>
<td>$550.8K</td>
<td align="right">8</td>
<td align="right">270</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$68.1</td>
<td>$68.0</td>
<td>$68.0</td>
<td>$80.00</td>
<td>$530.4K</td>
<td align="right">8</td>
<td align="right">288</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$67.1</td>
<td>$67.1</td>
<td>$67.1</td>
<td>$80.00</td>
<td>$503.2K</td>
<td align="right">8</td>
<td align="right">96</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$67.7</td>
<td>$67.6</td>
<td>$67.6</td>
<td>$80.00</td>
<td>$471.1K</td>
<td align="right">8</td>
<td align="right">186</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$68.1</td>
<td>$68.0</td>
<td>$68.0</td>
<td>$80.00</td>
<td>$122.4K</td>
<td align="right">8</td>
<td align="right">487</td>
</tr>
</tbody>
</table>

<h3>About Tenet Healthcare</h3>
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Following our analysis of the options activities associated with Tenet Healthcare, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Tenet Healthcare</h3>
<ul>
<li>Currently trading with a volume of 1,180,448, the THC's price is down by -2.04%, now at $148.74. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 77 days.</li>
</ul>
<h3>What The Experts Say On Tenet Healthcare</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $197.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Tenet Healthcare, maintaining a target price of $190. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Tenet Healthcare, which currently sits at a price target of $205. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Tenet Healthcare, which currently sits at a price target of $196. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Tenet Healthcare, targeting a price of $217. 
&#x2A; An analyst from Cantor Fitzgerald has decided to maintain their Overweight rating on Tenet Healthcare, which currently sits at a price target of $177. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tenet Healthcare with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

Check Out What Whales Are Doing With THC

Whales with a lot of money to spend have taken a noticeably bearish stance on Tenet Healthcare.
Looking at options history for Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $225,654 and 5, calls, for a total amount of $627,150.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $80.0 and $175.0 for Tenet Healthcare, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Tenet Healthcare stands at 538.5, with a total volume reaching 3,082.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Tenet Healthcare, situated within the strike price corridor from $80.0 to $175.0, throughout the last 30 days.
<h3>Tenet Healthcare Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731697233_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>THC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$78.0</td>
<td>$73.6</td>
<td>$76.53</td>
<td>$80.00</td>
<td>$382.6K</td>
<td>95</td>
<td align="right">50</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.1</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$175.00</td>
<td>$109.8K</td>
<td>1.9K</td>
<td align="right">0</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.2</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$175.00</td>
<td>$66.0K</td>
<td>1.9K</td>
<td align="right">743</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$6.8</td>
<td>$6.3</td>
<td>$6.55</td>
<td>$155.00</td>
<td>$44.8K</td>
<td>99</td>
<td align="right">20</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.1</td>
<td>$2.85</td>
<td>$3.0</td>
<td>$175.00</td>
<td>$36.9K</td>
<td>1.9K</td>
<td align="right">994</td>
</tr>
</tbody>
</table>

<h3>About Tenet Healthcare</h3>
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Following our analysis of the options activities associated with Tenet Healthcare, we pivot to a closer look at the company's own performance.
<h3>Where Is Tenet Healthcare Standing Right Now?</h3>
<ul>
<li>With a volume of 793,505, the price of THC is down -5.36% at $153.93. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 83 days.</li>
</ul>
<h3>Professional Analyst Ratings for Tenet Healthcare</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $189.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Tenet Healthcare, maintaining a target price of $195. 
&#x2A; Consistent in their evaluation, an analyst from Goldman Sachs keeps a Buy rating on Tenet Healthcare with a target price of $196. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Tenet Healthcare, targeting a price of $190. 
&#x2A; An analyst from Truist Securities downgraded its action to Buy with a price target of $190. 
&#x2A; Maintaining their stance, an analyst from Cantor Fitzgerald continues to hold a Overweight rating for Tenet Healthcare, targeting a price of $177. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Tenet Healthcare, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

What the Options Market Tells Us About Tenet Healthcare

Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Overweight and raises the price target from $171 to $190.

News

Price Target

Analyst Ratings

Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $190

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Overweight and raises the price target from $195 to $205.

Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $205

Cantor Fitzgerald analyst Sarah James maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Overweight and raises the price target from $168 to $177.

Cantor Fitzgerald Maintains Overweight on Tenet Healthcare, Raises Price Target to $177

Goldman Sachs analyst Jamie Perse maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Buy and raises the price target from $173 to $196.

Goldman Sachs Maintains Buy on Tenet Healthcare, Raises Price Target to $196

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Outperform and raises the price target from $174 to $183.

RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $183

Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Buy and raises the price target from $180 to $190.

Reiteration

Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $190

UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Buy and raises the price target from $197 to $217.

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $217

Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) has outperformed the market over the past 5 years by 28.69% on an annualized basis producing an average annual return of 42.33%. Currently, Tenet Healthcare has a market capitalization of $15.18 billion. 
Buying $1000 In THC: If an investor had bought $1000 of THC stock 5 years ago, it would be worth $6,120.94 today based on a price of $158.41 for THC at the time of writing.
<h3>Tenet Healthcare's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730228418_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Tenet Healthcare Stock In The Last 5 Years

On Tuesday,&nbsp;Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>)&nbsp;reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41594927/tenet-reports-strong-third-quarter-2024-results-raises-2024-financial-outlook" rel="noreferrer noopener">third-quarter</a> sales of $5.12 billion, up around 1.1% year over year, beating the&nbsp;consensus of $5.05 billion and management <a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/39934114/hospital-operator-tenet-healthcare-exceeds-earnings-expectations-announces-share-buyback-of-1-5b" rel="noreferrer noopener">guidance of $5 billion—$5.1 billion</a>.
Tenet Healthcare operates hospitals and healthcare facilities.
The company reported adjusted EPS of $2.93, up from $1.44 a year ago, beating the guidance of $2.16-$2.58 and the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">consensus of $2.37</a>.
&#8220;Our businesses continue to produce strong results and generate robust free cash flow with same-store revenue growth and profitability well above our expectations due to the focused execution of our strategy and disciplined operations,&#8221; said Saum Sutaria, Chairman and CEO of Tenet.
Adjusted EBITDA&nbsp;was $978 million compared to $854 million a year ago, reflecting strong same-hospital admissions growth, ambulatory net revenue per case growth, favorable payer mix, and increased Medicaid supplemental <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41594927/tenet-reports-strong-third-quarter-2024-results-raises-2024-financial-outlook" rel="noreferrer noopener">revenues in Michigan</a>.
Tenet&#8217;s free cash flow was $1.78 billion for the nine months ended September 30, 2024, up 76% year over year.
Ambulatory segment revenues increased 21% to $1.14 billion, driven by net revenue per case growth, facility acquisitions, and increased service lines.
Surgical business same-facility system-wide net patient service revenues increased 8.7%, with cases up 1.0% and net revenue per case up 7.6%.
Hospital Operations and Services revenues declined 3.4% to $3.98 billion, primarily due to the impact of hospital divestitures in the first quarter of 2024. This was partially offset by strong same-hospital admissions growth, favorable payer mix, and improved pricing yield.
Same-hospital net patient service revenue per adjusted admission increased 3.3% year-over-year.
In October, the company completed the sale of its 70% majority ownership interest in Brookwood Baptist Health in Birmingham, Alabama, to Orlando Health. The completed transaction included five hospitals and other related operations.
Outlook: Tenet Healthcare revised its fiscal year 2024 revenues guidance to $20.6 billion—$20.8 billion, compared to prior guidance of $20.6 billion—$21 billion and the consensus of $20.82 billion.
The guidance includes Hospital segment sales of $16.225 billion —$16.375 billion and Ambulatory Segment sales of $4.375 billion—$4.425 billion, compared to prior guidance of $16.28 billion—$16.53 billion and $4.33 billion—$4.48 billion, respectively.
The company forecasts adjusted EPS of $11.12-$11.73 compared to prior guidance of $10.41-$11.12 and a consensus of $10.56.
Price Action:&nbsp;At last check on Tuesday, THC stock was up 12.01% at $156.18.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/10/41596761/pfizer-q3-earnings-revenue-and-profit-on-heightened-demand-for-paxlovid-expects-10-billion-in-202" target="_blank" rel="noreferrer noopener">Pfizer Q3 Earnings: Revenue And Profit Beat On Heightened Demand For Paxlovid, Expects $10 Billion In 2024 Revenue From COVID Products</a></li>
</ul>

Earnings

Guidance

Health Care

Movers

General

Healthcare Facilities Operator Tenet Healthcare Boosts Annual Forecast On Same-store Revenue And Free Cash Flow Growth

Tenet Revises FY24 Net Operating Revenues Outlook From $20.60B - $21B To $20.60B - $20.80B (Est $20.816B), Raises Adj EPS From $10.41 - $11.12 To $11.12 - $11.73 (Est $10.56)

Tenet Expects Q4 Net Operating Revenues Of $5.007B - $5.207B (Est $5.29B), Adjusted EPS Of $2.69 - $3.31 (Est $2.88)

WIIM

Tenet Healthcare shares are trading higher after the company reported better-than-expected Q3 financial results.

Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) reported quarterly earnings of $2.93 per share which beat the analyst consensus estimate of $2.37 by 23.63 percent. This is a 103.47 percent increase over earnings of $1.44 per share from the same period last year. The company reported quarterly sales of $5.12 billion which beat the analyst consensus estimate of $5.05 billion by 1.37 percent. This is a 1.11 percent increase over sales of $5.07 billion the same period last year.

Earnings Beats

Tenet Healthcare Q3 2024 Adj EPS $2.93 Beats $2.37 Estimate, Sales $5.12B Beat $5.05B Estimate

In the current market session, Tenet Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) share price is at $141.00, after a 0.88% spike. Moreover, over the past month, the stock fell by 13.30%, but in the past year, increased by 162.96%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1730125041_0.png" alt="Past Year Chart" />

<h3>Comparing Tenet Healthcare P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Tenet Healthcare has a lower P/E than the aggregate P/E of 32.69 of the Health Care Providers &amp; Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730125041_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

P/E Ratio Insights for Tenet Healthcare

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>ICON plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) shares plummeted 25.95% after the company reported <a href="https://www.benzinga.com//node/41500867" target="_blank" rel="noreferrer noopener">worse-than-expected results</a>. Several analysts also cut the <a href="https://www.benzinga.com/quote/iclr/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) stock tumbled 20.21% after it reported mixed third-quarter results and cut its <a href="https://www.benzinga.com//node/41455012" target="_blank" rel="noreferrer noopener">FY24 EPS below estimates</a>. Multiple analysts cut the <a href="https://www.benzinga.com/quote/gpc/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) shares dipped 15.97% after the company reported <a href="https://www.benzinga.com//node/41503948" target="_blank" rel="noreferrer noopener">third-quarter financial results</a>. Analysts trimmed the <a href="https://www.benzinga.com/quote/nem/analyst-ratings" target="_blank" rel="noreferrer noopener">stock&#8217;s price target</a>.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) stock lost 14.71% last week. Several healthcare stocks and hospital operators fell in possible sympathy with HCA Healthcare, which declined on Q3 earnings.</li>
<li>Universal Health Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) stock fell 14.33% last week after the company reported <a href="https://www.benzinga.com//node/41530333" target="_blank" rel="noreferrer noopener">Q3 financial results</a>.</li>
<li>HCA Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) stock fell 12.51% after reporting <a href="https://www.benzinga.com//node/41544243" target="_blank" rel="noreferrer noopener">worse-than-expected Q3 financial results</a>. The company expects Hurricane Helene&#8217;s impact to continue in 2025.</li>
<li>TopBuild Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLD#NYSE">BLD</a>) stock lost 11.48% last week as homebuilding stocks <a href="https://www.benzinga.com//node/41317881" target="_blank" rel="noreferrer noopener">took a beating</a> due to Hurricane Milton&#8217;s impact.</li>
<li>Carlisle Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>) fell 11.45% last week on <a href="https://www.benzinga.com//node/41529849" target="_blank" rel="noreferrer noopener">worse-than-expected Q3 performance</a>.</li>
<li>Teradyne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) stock declined 11.34% after it reported <a href="https://www.benzinga.com//node/41503363" target="_blank" rel="noreferrer noopener">third-quarter financial results</a>. Some analysts trimmed the <a href="https://www.benzinga.com/quote/ter/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Comfort Systems USA, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) stock declined 11.27% after the company reported <a href="https://www.benzinga.com//node/41530044" target="_blank" rel="noreferrer noopener">worse-than-expected Q3 sales results</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/10/41560908/tesla-li-auto-and-microstrategy-are-among-top-10-large-cap-gainers-last-week-oct-21-oct-25-are-the">Tesla, Li Auto And MicroStrategy Are Among Top 10 Large Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?</a></li>
</ul>

Large Cap

ICLR

Genuine Parts Company, Universal Health Services, And TopBuild Are Among Top 10 Large Cap Losers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?

SGRY

Shares of healthcare stocks and hospital operators are trading lower in possible sympathy with HCA Healthcare, which fell after reporting Q3 eranings.

Investors with a lot of money to spend have taken a bullish stance on Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with THC, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Tenet Healthcare.
This isn't normal.
The overall sentiment of these big-money traders is split between 70% bullish and 10%, bearish.
Out of all of the options we uncovered, 9 are puts, for a total amount of $536,613, and there was 1 call, for a total amount of $36,480.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $105.0 to $155.0 for Tenet Healthcare over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Tenet Healthcare's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tenet Healthcare's whale activity within a strike price range from $105.0 to $155.0 in the last 30 days. 
<h3>Tenet Healthcare Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729780227_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$6.9</td>
<td>$6.1</td>
<td>$6.1</td>
<td>$145.00</td>
<td>$128.7K</td>
<td style="text-align: right;">946</td>
<td style="text-align: right;">131</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$6.9</td>
<td>$6.2</td>
<td>$6.2</td>
<td>$145.00</td>
<td>$79.8K</td>
<td style="text-align: right;">946</td>
<td style="text-align: right;">442</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$6.3</td>
<td>$6.2</td>
<td>$6.2</td>
<td>$145.00</td>
<td>$73.1K</td>
<td style="text-align: right;">946</td>
<td style="text-align: right;">931</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$6.5</td>
<td>$6.2</td>
<td>$6.2</td>
<td>$145.00</td>
<td>$62.0K</td>
<td style="text-align: right;">946</td>
<td style="text-align: right;">716</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$6.9</td>
<td>$6.2</td>
<td>$6.2</td>
<td>$145.00</td>
<td>$48.9K</td>
<td style="text-align: right;">946</td>
<td style="text-align: right;">521</td>
</tr>
</tbody>
</table>

<h3>About Tenet Healthcare</h3>
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
In light of the recent options history for Tenet Healthcare, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Tenet Healthcare's Current Market Status</h3>
<ul>
<li>With a trading volume of 208,882, the price of THC is down by -2.13%, reaching $154.26.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 5 days from now.</li>
</ul>
<h3>What The Experts Say On Tenet Healthcare</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $182.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $168. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $168. 
&#x2A; An analyst from Truist Securities persists with their Buy rating on Tenet Healthcare, maintaining a target price of $180. 
&#x2A; Reflecting concerns, an analyst from Keybanc lowers its rating to Overweight with a new price target of $200. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Tenet Healthcare, maintaining a target price of $195. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Tenet Healthcare, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Behind the Scenes of Tenet Healthcare's Latest Options Trends

Looking into the current session, Tenet Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) shares are trading at $154.83, after a 1.77% decrease. Over the past month, the stock decreased by 6.13%, but over the past year, it actually went up by 191.47%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1729779314_0.png" alt="Past Year Chart" />

<h3>Tenet Healthcare P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 34.07 in the Health Care Providers &amp; Services industry, Tenet Healthcare Inc. has a lower P/E ratio of 5.74. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1729779314_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

A Look Into Tenet Healthcare Inc's Price Over Earnings

Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services

Wells Fargo raised the firm's price target on Tenet Healthcare (THC) to $205 from $195 and keeps an Overweight rating on the shares. Following Q3 e...

Tenet Healthcare price target raised to $205 from $195 at Wells Fargo

In a report released yesterday, Steve Baxter from Wells Fargo maintained a Buy rating on Tenet Healthcare (THC – Research Report), with a price tar...

Wells Fargo Sticks to Their Buy Rating for Tenet Healthcare (THC)

Hospital stocks could see negative impact under Trump

Trump re-election: KeyBanc says watch these health and consumer stocks

13 Cheap small/mid-cap buy-rated stocks with higher Beta

Jefferies analyst Brian Tanquilut maintained a Buy rating on Tenet Healthcare (THC – Research Report) today and set a price target of $200.00. The ...

Tenet Healthcare (THC) Receives a Buy from Jefferies

Commure announced that Tenet Healthcare (THC) Corporation has selected Commure Scribe, an ambient AI platform, to be launched across its employed p...

Comments

Tenet Healthcare

Notizie

Ultime notizie per Tenet Healthcare (NYSE:THC) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO